Corporations are a critical part of this partnership to elevate the health of those disproportionately affected by cancer. While the initial focus is to recruit existing CEO Roundtable on Cancer companies, recruitment will not stop there.
We do not seek a one-time check from corporations because we want committed partners seeking to build relationships for the life of this initiative (7-10 years) and beyond. A key output is activation of employees (especially HBCU and HSI alumni and employee resource groups) and company networks in their communities as well as foundations and private philanthropists.
The experience of companies who employ our science-based health and well-being accreditation tool (the Cancer Gold Standard) helps them mentor other companies, colleges, and universities to achieve the same high level of cancer prevention, detection, treatment, and access to care in their work environment and beyond. Today 200+ companies with more than 7 million employees benefit from these standards.
Learning and networking opportunities, internships and careers for students, opportunities to influence policy, and ultimately to multiply their impact on health disparities are benefits available to both university and corporate partners.
With our Project Data Sphere research platform, Universities and life science companies can easily access and share high-quality data from completed clinical trials - giving them the ability to aggregate data and work together to improve clinical care.
Corporate partners are:
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information visit https://www.amgen.com/
“While much progress has been made against cancer over the years, that progress has not been shared equally,” said Robert A. Bradway, CEO of Amgen, which makes medicines that treat one out of every five cancer patients in the U.S. “I’m confident that this initiative will lead to expanded participation in cancer clinical trials, more equitable access to new treatments, and improved health outcomes for patients.”
Merck
For over 130 years, Merck, known as MSD outside the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs, and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
“We know that cancer diagnoses in African American and Hispanic/Latino populations are often made too late. The reasons for this are complex, ranging from the social determinants of health, through lack of access – and in some cases, lack of knowledge and best-in-class tools,” said Dr. Julie L. Gerberding, Chief Patient Officer and Executive Vice President, Population Health and Sustainability at Merck. “The Going for Gold initiative is a wonderful way to build exemplars that begin the process of addressing these health disparities in Centers of Excellence that are academically positioned, but also positioned in communities that have the most to benefit from their success.”
SAS
SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®. For more information, visit https://www.sas.com/en_us/home.html.
“Through the Going for Gold initiative and access to clinical trial data and powerful analytics, HBCUs and HSIs can lead a generation of research into cancer’s disparate effects on communities of color,” said SAS CEO Jim Goodnight. “I encourage other companies to join us in supporting community and education efforts that lead to more equitable health care.”
Racing Toward Diversity
Racing Toward Diversity magazine showcases the best diversity efforts and initiatives being made today. Written with business and educational audiences in mind. Stories highlight messages from influential leaders and their organizations. With our concentration on driving strong relevant content through global social media platforms our quarterly magazine, daily newspaper and blog reaches over 3.5 million readers, via Twitter (@fleejack and @race2diversity) Facebook, Google+ and LinkedIn.
Fields Jackson, Jr. is currently the Founder and CEO and Chief Cheerleader of Racing Toward Diversity Magazine, Cary, NC, adjunct professor, teaching Principles of Business at Shaw University, Raleigh, NC, and former Executive Director of the HBCU Business Dean Round-table.
Visit: https://www.racingtowarddiversity.com/
Jasper Health
Jasper Health is a digital guiding, navigation, and engagement experience that improves the lives of people living with cancer, those at high risk for cancer, and their caregivers. Its all-in-one oncology platform provides psychosocial support interventions while enabling connected care with the broader healthcare system. Our team includes seasoned leaders with decades of experience in digital health, clinical care, data science, and consumer engagement. Founded at Redesign Health, a company that powers innovation in healthcare, we believe that powerful technology and passionate people can relieve some of the stress of organizing care. To learn more, visit www.hellojasper.com.